Skip to content

ADVIA Centaur Herpes-2 IgG 10720849Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · Herpes-2 IgG (HSV2) ADVIA Centaur - RGT – 100T · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Feb 8, 2021Class IITerminated

    Potential false positive HSV results. Siemens Healthcare Diagnostics, Inc. initiated a correction for ADVIA Centaur4P Herpes-2 lgG (HSV2) Onboard Stability and Calibration Frequency (Interval) Failures on the ADVIA Centaur XP System and ADVIA Centaur XPT System.

    Z-1274-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Other Enzyme linked immunoabsorbent assay, herpes simplex virus, non-specific devices

All Enzyme linked immunoabsorbent assay, herpes simplex virus, non-specific devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page